Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.
- Revenue: $14.31M. Running result $14.31M. Product And Service Other: $694K. Toripalimab: $13.61M.
- Cost of revenue: −$4.24M. Running result $10.07M.
- Gross profit: $10.07M. Running result $10.07M.
- Research and development: −$21.44M. Running result −$11.38M.
- Selling, general and administrative: −$20.95M. Running result −$32.33M.
- Operating income: −$32.33M. Running result −$32.33M.
- Other expense: −$1.02M. Running result −$33.35M.
- Pre-tax loss: −$33.35M. Running result −$33.35M.
- Income tax benefit: $0. Running result −$33.35M.
- Discontinued operations (net of tax): $12.72M. Running result −$20.63M.
- Net loss: −$20.63M. Running result −$20.63M.
